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Abstract: A convergent and asymmetric synthesis of the 
tricyclic B,C,D-ring core structure of croomine has been 
achieved, using aminolysis reactions of chiral vinyl epox-
ides and the RCM reaction  
 
Key words: oxazolindone, pyrrolidine, ring-closing me-
tathesis, azepine, Stemona alkaloid. 
 
The Stemona group of alkaloids includes more than 
40 different natural products that have been structu-
rally classified into five different groups.1 The pyr-
rolo[1,2-a]azepine (1-azabicyclo[5.3.0]decane) 
nucleus is common to all compounds in these 
groups. A few of these alkaloids do not fit these five 
structural groups and have a more complex bridged 
structure or ring structures that most likely arise 
from initial oxidative cleavage of the pyrrolo[1,2-
a]aze 
pine ring system.1 In 2003 we reported the structure 
of stemocurtisine, the first example of a Stemona 
alkaloid with a pyrido[1,2-a]azepine A,B-ring sys-
tem, isolated from the roots of S. curtisii.2  Later in 
that year Hofer and Greger reported the isolation of 
four other Stemona alkaloids with the pyrido[1,2-
a]azepine A,B-ring system plus stemocurtisine.3  
These alkaloids represent a new and sixth structural 
group for Stemona alkaloids.  Extracts of the roots 
of Stemona species have been used in traditional 
Chinese medicine for the treatment of various respi-
ratory diseases and as anthelmintic agents for do-
mestic animals.1 The biological activities and the 
structural diversity and relative complexity of these 
alkaloids has attracted the attention of many syn-
thetic chemists. Their efforts have resulted in the 
total synthesis of several Stemona alkaloids4 and the 
publication of model synthetic studies.5 
We report here our efforts to develop a convergent 
synthesis of the tricyclic B,C,D-ring core structure 
of croomine (1) based on the retro-synthetic analysis 
shown in Scheme 1. Our analysis suggested that the 
A and D rings could be prepared by an oxidative 
lactonization reaction of the tetrol 2, while the B-
ring could be secured via a N-alkylation reaction.   
Compound 2 could be obtained from the diene 3 via 
a ring-closing metathesis reaction.6,7  The diene 3 
should be available from an epoxide-aminolysis 
reaction between the vinyl epoxides 4 or 7 and the 
allylic amines 5 and 6, respectively.6,8,9   
As model studies to test the viability of our proposed 
synthesis we have prepared the chiral allylic amine 
11, a structurally simpler analogue of 6, and the 
vinyl epoxide 12, the nor-methyl analogue of 7, and 
used them as building blocks to prepare a molecule 
having the tricyclic B,C,D-ring core structure of 
croomine (1).  Compound 11 was prepared from the 
chiral cis-epoxide 9 (ee 92-94%), which was readily 
available in 5 steps (38% overall) from the known 
PMB protected 5-hexyn-1-ol 810 using chemistry 
already described by us (Scheme 2).8,9 Aminolysis of 
9 as a suspension in aqueous ammonia (28%) in a 
sealed Teflon vessel with heating in a microwave 
reactor (Milestone, ETHOS SEL microwave labsta-
tion)6 at 110oC for 30 min, with strict temperature 
control, gave regioselectively, the amino alcohol 10 
in 98% yield which was converted to its correspond-
ing O-TBS ether 11 in 85% yield as a single diaste-
reomer (Scheme 2).  The chiral epoxide 12 was as 
previously described from this laboratory.8  
Scheme 2 
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Reagents: (a) aqueous ammonia (28%), 110oC, 30 
min, microwave heating (98%). (b) TBSCl, imida-
zole, MeCN, RT (85%). 
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Scheme 1. Retrosynthetic analysis of croomine (1). 
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Reagents (a) LiOTf, CH3CN, 130 
oC, 4 d (95 %); (b) triphosgene, NEt3, CH2Cl2 -40 
oC (84 %); (c) Grubbs' cat., 
CH2Cl2, reflux, 7 d (93 %); (d) Pd/C, H2, EtOAc, RT, 1 h (95 %); (e) n-Bu4NF, THF, RT (100 %); (f) NaOH, MeOH, 
H2O, 100 
oC, microwave, 90 min (93 %); (g) TBDPSCl, imidazole, CH3CN, 75 
oC, 2 d (81 %); (h) CAN, CH3CN, 
H2O, CH2Cl2 (93 %); (i) PPh3, CBr4, NEt3, 0 
oC to RT (81 %); (j) HCl (38 %), MeOH, CHCl3, 90 
oC, 3 d (84 %); (k) 
TEMPO, BAIB, AcOH, RT (28 %). 
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Heating a mixture of 11 and 12 and lithium triflate (1.5 
equiv) in acetonitrile solution at 130 oC for 4 days in a 
sealed tube provided the amino alcohol 13 (78%, ee 
estimated ca 95% due to removal of most of the unde-
sired enentiomers of 11 and 12 as the diastereomer of 13, 
but not determined) and its diastereomer (not shown, 
17%) that were readily separated by column chromato-
graphy (Scheme 3).6  The latter compound arises from 
the reaction of ent-11 with 12 and 11 with ent-12. Treat-
ment of 13 with triphosgene at –40 oC in the presence of 
base (Et3N) gave the oxazolidinone 14 in 84% yield, 
along with an aziridine (not shown, 14%) that arises 
from reaction of triphosgene with the secondary hydrox-
yl group of 13 followed by intramolecular SN2 displace-
ment by the nitrogen atom at the carbon bearing the 
activated hydroxyl.  The low temperature was required to 
minimise the formation of this aziridine.  The oxazolidi-
none 14 was treated under standard RCM conditions 
(Grubbs’ 1st generation catalyst and high dilution in dich-
loromethane solution).7,11 The reaction was slow requir-
ing 7 days of heating at reflux and high catalyst loading 
(50 mol %), however the yield of the 2,5-dihydropyrrole 
15 was excellent (93%).  Catalytic hydrogenation of the 
alkene group in 15 smoothly gave the pyrrolidine 16 
without loss of the PMB group.   Attempts to remove the 
PMB group from the analogous tris-TBS analogue of 17 
resulted in cleavage of the primary TBS group and hence 
16 was treated first with tetra-n-butylammonium fluoride 
(TBAF) to give the corresponding diol, which upon base 
catalysed hydrolyses of the oxazolidinone group and 
finally O-silylation with tert-butylchlorodiphenylsilane 
(TBDPSCl) gave the pyrrolidine 17 in 75 % overall 
yield.  The primary O-PMB group was removed under 
oxidative conditions using ceric ammonium nitrate 
(CAN) to give the primary alcohol 18 in 93% yield 
which was converted to the 1H-pyrrolo[1,2-a]azepine 19 
in 81% yield under standard cyclization conditions.8,12  
Compound 19 was treated with aqueous hydrochloric 
acid to give the triol 20.13  Oxidation of this triol to give 
the corresponding keto-lactone 23 proved difficult.  For 
example, the use of tetrapropylammoniumperruthenate 
(TPAP)/N-methylmorpholine-N-oxide (NMO), a reagent 
combination that we have used successfully before to 
prepare a lactone from a related 1,4-diol,6 gave a mixture 
of products including ones that showed aldehyde signals 
in the 1H NMR spectra.  When the oxidizing system 
2,2,6,6-tetramethyl-1-piperidinyloxyl (TEMPO, catalyt-
ic)/bis-acetoxy iodobenzene (BAIB, stoichiometric)14,15 
was employed in acetic acid as solvent, the product 22 
was isolated in 28% yield having a novel 5,9-epoxy-1H-
pyrrolo[1,2-a]azepine tricyclic ring structure.  This struc-
ture most likely arises from oxidation of the tertiary 
amine to the corresponding cyclic iminium ion 21 fol-
lowed by ring closure through the secondary hydroxyl in 
the azepine ring.  The structure of 22 was supported by 
COSY, 13C/DEPT and HSQC NMR experiments and 
mass spectrometry.14  The hemiaminal carbon (C-5) was 
evident as a methine carbon at 96 ppm in the 13C/DEPT 
NMR spectra. 
In conclusion, we have developed a convergent and 
asymmetric synthesis of the tricyclic B,C,D-ring 
core structure of croomine, using aminolysis reac-
tions of chiral vinyl epoxides and the RCM reaction.  
We are currently refining this strategy and develop-
ing syntheses of compounds 4 and 5 with the view of 
preparing croomine in the near future. 
Acknowledgment. We thank the University of Wollon-
gong for PhD scholarships to KBL and the Australian 
Research Council for financial support 
References and Notes 
 
(1) Pilli, R. A.; Ferreira de Oliveira, M. C. Nat. 
Prod. Rep. 2000, 17, 117-127. 
(2) Mungkornasawakul, P.; Pyne, S. G.; Jatisatienr, 
A.; Supyen, D.; Lie, W.; Ung, A. T.; Skelton, B. 
W.; White, A. H.  J. Nat. Prod.  2003, 66, 980-
982. 
(3) Kaltenegger, E.; Brem, B.; Mereiter, K.; Kal-
chhauser, H.; Kählig, H.; Hofer, O.; Vajrodaya, 
S.; Greger, H.  Phytochem. 2003, 63, 803-816. 
(4) Williams, D. R.; Brown, D. L.; Benbow; J. W.; 
J. Am. Chem. Soc. 1989, 111, 1923-1925. Chen, 
C. Y.; Hart, D. J.; J. Org. Chem.1990, 55, 6236-
6240. Chen, C. Y.; Hart, D. J.; J. Org. Chem. 
1993, 58, 3840-3849. Wipf, P.; Kim, Y.; 
Goldstein; D. M.; J. Am. Chem. Soc. 1995, 117, 
11106-11112. Martin, S. F.; Barr, K. J.; J. Am. 
Chem. Soc. 1996, 118, 3299-3300. Morimoto, 
Y.; Iwahashi, M.; Nishida, K.; Hayashi, Y.; Shi-
rahama, H.  Angew. Chem Int. Ed. 1996, 35, 
904-906. Jacobi, P. A.; Lee, K.; J. Am. Chem. 
Soc. 1997, 119, 3409-3410. Kende, A. S.; Smal-
ley, T. L., Jr.; Huang, H.; J. Am. Chem. Soc. 
1999, 121, 7431-7432. Martin, S. F.; Barr, K. J.; 
Smith, D. W.; Bur, S. K.; J. Am. Chem. Soc. 
1999, 121, 6990-6997. Jacobi, P. A.; Lee, K.; J. 
Am. Chem. Soc. 2000, 122, 4295-4303. Wil-
liams, D. R.; Fromhold, M. G.; Earley, J. D.; 
Org. Lett. 2001, 3, 2721-2724. Kende, A. S.; 
Martin Hernando, J. I.; Milbank, J. B. J.; Org. 
Lett. 2001, 3, 2505-2508.  Morimoto, Y.; Iwaha-
shi, M.; Kinoshita, T.; Nishida, K.  Chem.Eur. J. 
2001, 7, 4107-4116. Kende, A. S.; Martin Her-
nando, J. I.; Milbank, J. B. J.    Tetrahedron 
2002, 58, 61-74. Wipf, P.; Rector, S. R.; Takaha-
shi, H.; J. Am. Chem. Soc. 2002, 124,14848-
14849. Ginn, J. D.; Padwa, A.; Org. Lett. 2002, 
4, 1515-1517.  Bruggemann, M.; McDonald, A. 
I.; Overman, L. E.; Rosen, M. D.; Schwink, L.; 
Scott, J. P.; J. Am. Chem. Soc. 2003, 125, 
15284-15285. Williams, D. R.; Shamim, K.; 
Reddy, J. P.; Amato, G. S.; Shaw, S. M. Org. 
Lett. 2003, 5, 3361-3364. 
(5) Xiang, L.; Kozikowski, A. P. Synlett 1990, 5, 
279-81.  Morimoto, Y.; Iwahashi, M. Synlett 
1995, 1221-2.  Rigby, J. H.; Laurent, S.; Cavez-
4 LETTER  
Template for SYNLETT and SYNTHESIS © Thieme  Stuttgart · New York 2013-03-01 page 4 of 6 
za, A.; Heeg, M. J.; J. Org. Chem. 1998; 63, 
5587-5591. Wipf, P.; Li, W.; J. Org. Chem. 
1999; 64, 4576-4577. Jung, S. H.; Lee, J. E.; 
Joo, H. J.; Kim, Sang H.; Koh, H. Y.  Bull. Ko-
rean Chem. Soc. 2000, 21, 159-160. Rigby, J. H. 
Synlett 2000, 1-12.  Hinman, M. M.; Heathcock, 
C. H.; J. Org. Chem. 2001, 66, 7751-7756. 
Velázquez, F.; Olivo, H. F.; Org. Lett. 2002, 4, 
3175-3178.  Boren, B.; Hirschi, J. S.; Reibens-
pies, J. H.; Tallant, M. D.; Singleton, D. A.; Su-
likowski, G. A.; J. Org. Chem. 2003; 68, 8991-
8995. 
(6) Lindsay, K. B.; Tang, M.; Pyne, S. G.  Synlett 
2002, 5, 731-734.   
(7) Davis, A. S.; Gates, N. J.; Lindsay, K. B.; Tang, 
M.; Pyne, S. G.  Synlett 2004, 6, 49-52. 
(8) Lindsay, K. B.; Pyne, S. G. J. Org. Chem., 2002 
67, 7774-7780.  
(9) Tang, M.; Pyne, S. G. J. Org. Chem. 2003, 68, 
7818-7824. 
(10) Hayashi, N.; Fujiwara, K.; Murai, A. Tetrahe-
dron 1997, 53, 12425-12468. 
(11) (1S,5S,7aS)-5-[(1S)-1-[[(1,1-
Dimethylethyl)dimethylsilyl]oxy]-5-
[(methoxyphenyl)methoxy]pentyl]-1-[3-[[(1,1-
dimethylethyl)dimethylsilyl]oxy]propyl]-5,7a-
dihydro-1H,3H-pyrrolo[1,2-c]oxazol-3-one 
(14). The diene 13 (547 mg, 0.826 mmol) was 
dissolved in dry DCM (95 mL), then Grubbs' 1st 
generation catalyst (338 mg, 0.413 mmol) was 
added.  The mixture was heated at reflux under 
N2 for 7d then cooled, before all volatiles were 
removed in vacuo to give a black oil.  The pure 
product was obtained by column chromatogra-
phy (increasing polarity from 10 % to 40 % 
EtOAc in pet. sp. as eluant), which gave a black 
oil.  This was dissolved in EtOAc (30 mL) and 
stirred with activated charcoal for 20 min to re-
move residual ruthenium, then filtered through 
celite.  Evaporation of the filtrate afforded the 
title compound (485 mg, 0.785 mmol, 92.6 %) 
as a colourless oil. []D
26: -86 (c 1.0, CHCl3). 
MS (ES+) m/z 634.5 (100 %) (M+1), HRMS 
(ES+) found 634.3975, calc for C34H59NO6Si2 
634.3959 (M+1). H (300 MHz, CDCl3): 0.04 
(6H, s, (CH3)2Si), 0.05 (6H, s, (CH3)2Si), 0.86 
(9H, s, (CH3)3CSi), 0.89 (9H, s, (CH3)3CSi), 
1.34-1.96 (10H, m, H2', H3', H4', H1'' and H2''), 
3.44 (2H, t, J=6.6 Hz, H5'), 3.62-3.74 (3H, m, 
H1' and H3''), 3.79 (3H, s, OCH3), 4.24-4.30 
(1H, m, H7a), 4.35 (1H, q, J=6.0 Hz, H1), 4.42 
(2H, s, OCH2Ar), 4.54 (1H, app. t, J=3.9 Hz, 
H5), 5.85-5.92 (2H, m, H6 and H7), 6.86 (2H, d, 
J=8.7 Hz, 2 x ArCH), 7.25 (2H, d, J=8.7 Hz, 2 x 
ArCH). C (75 MHz, CDCl3):  -5.4 (q, 
(CH3)2Si), -4.6 (q, CH3Si), -4.4 (q, CH3Si), 18.0 
(s, (CH3)3CSi), 18.3 (s, (CH3)3CSi), 22.2 (t, 
C3'), 25.8 (q, (CH3)3CSi), 25.9 (q, (CH3)3CSi), 
27.9, 29.9, 31.9, 33.6 (t, C2', C4', C1'' and C2''), 
55.2 (q, OCH3), 62.3 (t, C3''), 70.0 (t, C5''), 70.6 
(d, C7a), 71.0 (d, C5), 72.5 (t, OCH2Ar), 73.3 
(d, C1'), 82.0 (d, C1), 113.7 (d, 2 x ArCH), 
129.2 (d, 2 x ArCH), 129.6, 132.2 (d, C6 and 
C7), 130.8 (s, ArC), 159.0 (s, ArC), 162.4 (s, 
C3). 
(12)  (3S,9S,9aS)-9-[[(1,1-
Dimethylethyl)diphenylsilyl]oxy]-3-[(1S)-1,4-
bis[[(1,1 dimethylethyl)diphenylsilyl]oxy]-
butyl]-1H-pyrrolo[1,2-a]azepine (19). The ami-
no alcohol 18 (727 mg, 0.744 mmol) was dis-
solved in DCM (60 mL), then the solution was 
cooled to 0 oC.  Carbon tetrabromide (604 mg, 
1.828 mmol) and triphenylphosphine (475 mg, 
1.828 mmol) were added, then the mixture was 
stirred at 0 oC for 10 min, before triethylamine 
(3.70 g, 36.56 mmol) was added.  The mixture 
was stirred at 0 oC for 5 h, then left to stand at 4 
oC for 20 h, then stirred at RT for 24 h.  The 
mixture was poured into water (50 mL) and ex-
tracted with DCM (3 x 20 mL).  The combined 
organic extracts were dried (MgSO4), filtered 
and evaporated to give a black semi-solid.  The 
pure products were obtained by column chroma-
tography (increasing polarity from 5 % to 25 % 
EtOAc in pet. sp. as eluant), which gave the title 
compound (451 mg, 0.470 mmol, 63.2 %) and 
the partially stable bromide intermediate.  The 
bromide intermediate was dissolved in DCM 
(10 mL) and triethylamine (5 mL), then heated 
at reflux for 3 h.  Work up and column chroma-
tography as described above gave further title 
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(13)  (3S,9S,9aS)-3-[(1S)-1,4-Dihydroxybutyl]-9-
hydroxy-1H-pyrrolo[1,2-a]azepine (20). The tri-
O-silyl ether 19 (61 mg, 0.0636 mmol) was dis-
solved in CHCl3 (0.5 mL), then MeOH (4.0 mL) 
and conc HCl (1.0 mL, 38 % w/w) were added.  
The mixture was heated in a sealed tube at 90 oC 
for 3d then cooled.  The mixture was poured in-
to ether (40 mL) and extracted with 1M HCl (3 
x 15 mL).  The combined aqueous extracts were 
evaporated to dryness in vacuo to give a gum.  
This was dissolved in water (2 mL) and applied 
to basic ion exchange resin (OH- form).  Elution 
with water (50 mL) and evaporation of the 
eluant gave the title compound (13 mg, 0.0534 
mmol, 83.9 %) as a pale brown gum. []D
22:  -
34 (c 1.3, MeOH). MS (CI+) m/z 244 (100 %) 
(M+1), HRMS (CI+) found 244.1916, calc for 
C13H26NO3 244.1913 (M+1). H (300 MHz, 
CDCl3): 1.30-2.10 (17H, m, H1, H2, H6, H7, 
H8, H2', H3' and 2 x OH), 2.85 (1H, ddd, 
J=12.3, 6.3, 2.4 Hz, H5a), 2.94-3.08 (2H, m, H3 
and H5b), 3.29 (1H, td, J=6.9, 2.4 Hz, H9a), 
3.38 (1H, ddd, J=9.0, 6.3, 2.4 Hz, H1'), 3.60-
3.76 (2H, m, H4'), 3.94 (1H, br. d, J=6.9 Hz, 
H9). C (75 MHz, CDCl3):  22.9 (t, C7), 27.9, 
28.9, 29.4, 30.1, 32.1, 34.8 (t, C1, C2, C6, C8, 
C2' and C3'), 52.5 (t, C5), 62.9 (t, C4'), 65.3 (d, 
C9a), 71.0 (d, C3), 72.6 (d, C9), 72.8 (d, C1'). 
(14)  (3S,5S,9S,9aS)-3-[(5S)-tetrahydro-5-oxo-2-
furanyl]-5,9-epoxy-1H-pyrrolo[1,2-a]azepine 
(22). The triol 20 (25 mg, 0.103 mmol) was dis-
solved in AcOH (2 mL), then TEMPO (5 mg, 
0.032 mmol) and BAIB (113 mg, 0.35 mmol) 
were added.  The mixture was stirred at RT for 
24 h, then Na2S2O3.5H2O (125 mg, 0.504 mmol) 
was added.  After 20 min the mixture was 
poured into 5 % NH4OH solution (40 mL) and 
extracted with DCM (3 x 20 mL).  The com-
bined organic extracts were dried (MgSO4) fil-
tered and evaporated in vacuo to give an oil.  
The pure product was obtained by column 
chromatography (2 % MeOH in DCM as eluant) 
which gave the title compound (7 mg, 0.029 
mmol, 28.6 %) as a pale yellow semi solid. MS 
(CI+) m/z 238 (100 %) (M+1). H (300 MHz, 
CDCl3):  0.80-2.00 (10H, m, H1a, H2, H6, H7, 
H8 and H4'a), 2.00-2.14 (1H, m, H1b), 2.25 
(1H, dddd, J=12.6, 8.1, 6.9, 5.7 Hz, H4'b), 2.53 
(1H, dd, J=9.6, 3.3 Hz, H3'a), 2.55 (1H, dd, 
J=9.6, 0.9 Hz, H3'b), 3.02 1H, ddd, J=10.2, 7.5, 
5.4 Hz, H3), 3.46-3.80 (1H, m, H9a), 4.02 (1H, 
d, J=1.5 Hz, H9), 4.37 (1H, dt, J=7.8, 7.2 Hz, 
H5'), 4.82 (1H, s, H5). C (75 MHz, CDCl3):  
16.8 (t, C7), 25.4 (t, C4'), 28.8 (t, C3'), 28.9, 
29.2 (t, C6 and C8), 31.5 (t, C2), 31.6 (t, C1), 
68.7 (d, C9a), 70.9 (d, C3), 78.9 (d, C9), 85.3 
(d, C5'), 96.0 (d, C5), 177.0 (s, C2). 
(15)  De Mico, A.; Margarita, R.; Parlanti, L.; Vesco-
vi, A.; Piancatelli, G. J. Org. Chem. 1997, 62, 
6974-6977. Paterson, I.; Tudge, M. Angew. 
Chem. Int. Ed . 2003, 42, 343-347. 
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